About: David Cunningham

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: David Cunningham Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) investigador (es) chercheur (fr) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq) onderzoeker (nl) researcher (en-ca) researcher (en-gb) researcher (en-us) investigador (ca) investigador (gl) investigador (ast) investigador (pt)
rdfs:label	David Cunningham (en) David Cunningham (es) David Cunningham (it) David Cunningham (nl) David Cunningham (sl) David Cunningham (ast) ডেভিড কানিংহাম (bn)
skos:prefLabel	David Cunningham (en) David Cunningham (es) David Cunningham (it) David Cunningham (nl) David Cunningham (sl) David Cunningham (ast) ডেভিড কানিংহাম (bn)
name	David Cunningham (en) David Cunningham (es) David Cunningham (it) David Cunningham (nl) David Cunningham (sl) David Cunningham (ast) ডেভিড কানিংহাম (bn)
given name	wds:Q38803238-709300A7-CF9D-49BD-9F88-CD2B1608FE2C
given name	David
instance of	wds:Q38803238-5AAED388-A8C6-4C1B-9A7B-209ED6AD681A
instance of	Homo sapiens
Nationale Thesaurus voor Auteursnamen ID	wds:Q38803238-e196a34c-e8b5-4672-a9fa-6fba6311060b
occupation	wds:Q38803238-EC3EFFC2-15DE-4C98-88CE-7CBC3E6C2835
employer	wds:Q38803238-4DCF6878-E161-40CA-8FF7-DD9DF58BF368 wds:Q38803238-7301DAEF-991F-4AAE-A994-9631B6758ACD wds:Q38803238-E7C15052-C017-4621-BD03-ABEDF9DCD750 wds:Q38803238-b149ae35-4b55-05c1-afb5-457e80fccd6e
sex or gender	wds:Q38803238-E542D5BA-6E01-4499-9828-B2910C0173D4
VIAF ID	wds:Q38803238-05226B63-00AA-43A5-ACC7-8A5294F7C5F3
family name	wds:Q38803238-DEA75ED7-9867-4B6E-AC1A-CD17856FAB1F
WorldCat Identities ID (superseded)	wds:Q38803238-B6FBA768-686C-4B50-840C-5931C8A0671D
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p202423980
VIAF ID	http://viaf.org/viaf/284204756
Nationale Thesaurus voor Auteursnamen ID	202423980
occupation	researcher
employer	The Royal Marsden NHS Foundation Trust University of London
sex or gender	male
VIAF ID	284204756
family name	Cunningham
WorldCat Identities ID (superseded)	viaf-284204756
Springer Nature person ID	wds:Q38803238-E3BD80F0-2609-465B-A0DF-BA17DB0882D6
ORCID iD	wds:Q38803238-4196A081-3896-4BB0-92AB-E47CE8777DE9
Dimensions author ID	wds:Q38803238-7BD96243-DE7A-470D-8B00-03E5628003D2
ORCID iD	https://orcid.org/0000-0001-5158-1069
Springer Nature person ID	01320161130.16
ORCID iD	0000-0001-5158-1069
Dimensions author ID	01320161130.16
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q38803238
is author of	Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma High-dose busulfan in patients with myeloma K-ras mutations in patients with early colorectal cancers Gastric cancer in 2012: Defining treatment standards and novel insights into disease biology Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer Targeting the human EGFR family in esophagogastric cancer Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus The Role of Routine Clinical Pretreatment 18F-FDG PET/CT in Predicting Outcome of Colorectal Liver Metastasis Managing patients treated with bevacizumab combination therapy. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Multiple myeloma: appearance at MR imaging Colorectal cancer CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial. The value of source data verification in a cancer clinical trial Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software